We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
As part of the Government's response to the Review of Medicines and Medical Devices Regulation (MMDR review), the TGA has implemented a priority pathway for the registration of novel prescription medicines for Australian patients.
The priority pathway provides a formal mechanism for faster assessment of vital and life-saving prescription medicines. The target timeframe of 150 working days is up to three months shorter than the standard prescription medicines registration process.
For details read priority review pathway: prescription medicines.